Raymond James Financial Inc Arbutus Biopharma Corp Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 10,504 shares of ABUS stock, worth $37,709. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,504Holding current value
$37,709% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
160Shares Held
99.7MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$77.9 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$46.2 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$41.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$32 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$30.1 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $538M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...